Poseida Therapeutics Inc. (PSTX) Social Stream



Poseida Therapeutics Inc. (PSTX): $1.99

-0.10 (-4.78%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Poseida Therapeutics Inc (PSTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Poseida Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-13 4 $40 $19 $26.333 $4.74 455.55%
2022-01-12 5 $40 $19 $25.75 $4.74 443.25%
2022-03-17 5 $40 $12 $23.75 $4.74 401.05%

The Trend in the Analyst Price Target


Over the past 36 weeks, PSTX's average price target has gone down $1.92.

PSTX reports an average of 251.06% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 2 30 20 25.00 8.85 182.49%
2021-05-15 2 30 20 25.00 8.40 197.62%
2021-09-04 3 40 17 25.67 8.17 214.2%
2021-09-20 3 40 17 25.67 7.98 221.68%
2022-01-07 5 40 19 25.75 6.39 302.97%

PSTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


PSTX's average broker recommendation rating improved by 0.25 over the prior 151 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PSTX as an investment opportunity.

  • Poseida Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 286.11% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, Poseida Therapeutics Inc's variance in analysts' estimates is lower than -168.3% of them.
  • In the context of Healthcare stocks, Poseida Therapeutics Inc's number of analysts covering the stock is higher than 96.23% of them.
  • Poseida Therapeutics Inc's average analyst price target is greater than 120.83% of Healthcare stocks.

In the Pharmaceutical Products industry, PASG, OYST, and OTLK are the three stocks most similar to Poseida Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is PSTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5727 seconds.